Established risk variants in genes such as CFH and ARMS2 have consistently been shown to play a pivotal role in AMD pathogenesis by influencing inflammation and complement activation in various populations as reviewed by Ismail, F et al. (2024). The gene discussed is CFH; the disease is age-related macular degeneration.